熱門資訊> 正文

ReShape Lifesciences重新获得纳斯达克合规

2025-06-27 21:53

ReShape Lifesciences (NASDAQ:RSLS) has regained compliance with Nasdaq requiring at least $2.5M in stockholders’ equity.
Source: Press release

More on ReShape Lifesciences

ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)
Financial information for ReShape Lifesciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。